Page 1

Particulars AUROBINDO PHARMA LIMITED ( CIN L24239TG1986PLC015190 ) Regd . Office : Plot No.2 , Maitrivihar , Ameerpet , Hyderabad - 500 038 , India Tel : +91 040 23736370 ; Fax : +91 40 23747340 ; Email : info@aurobindo.com STATEMENT OF UNAUDITED STANDALONE FINANCIAL RESULTS FOR THE QUARTER AND HALF YEAR ENDED 30.09.2021 30.09.2021 Quarter ended 30.06.2021 Unaudited Unaudited ( Rs . In lakhs ) Year ended 31.03.2021 Audited Half year ended 30.09.2020 Unaudited 30.09.2021 Unaudited 30.09.2020 Unaudited 1 Revenue from operations ( a ) Net sales / income from operations 287,218 ( b ) Other operating income 1,100 288,564 811 Total revenue from operations 288,318 289,375 444,959 9,891 454,850 575,782 1,911 577,693 779,314 18,136 797,450 1,562,218 20,150 1,582,368 2 Other income ( a ) Foreign exchange gain ( net ) ( refer note 7 ) . 4,924 2,703 2,949 7,627 8,147 18,544 ( b ) Others 3,313 1,692 1,368 5,005 8,265 40,442 Total other income 8,237 4,395 4,317 12,632 16,412 58,986 Total income ( 1 + 2 ) 296,555 293,770 459,167 590,325 813,862 1,641,354 3 Expenses ( a ) Cost of materials consumed 140,217 ( b ) Purchase of stock - In - trade 583 ( c ) Changes in inventories of finished goods , stock - in - trade and work - in - progress ( d ) Employee benefits expense 12,836 38,928 154,349 593 ( 11,171 ) 43,077 184,423 294,566 245 1,176 36,399 1,665 364,526 759 ( 2,371 ) 721,573 2,609 299 42,957 82,005 85,689 173,543 ( e ) Finance costs 344 506 645 850 1,688 2,868 ( f ) Depreciation and amortisation expense 9,818 11,465 12,125 21,283 24,171 48,799 ( g ) Other expenses 61,781 61,446 70,074 123,227 132,045 272,362 Total expenses 4 Profit before tax ( 1 + 2-3 ) 5 Tax expense Current tax Deferred tax Total tax expense 6 Profit for the period / year ( 4-5 ) 7 Other Comprehensive income 264,507 260,265 346,868 524,772 606,507 1,222,053 32,048 33,505 112,299 65,553 207,355 419,301 12,204 14,344 32,087 26,548 56,597 104,334 76 ( 2,346 ) 519 ( 2,270 ) 312 3,676 12,280 11,998 32,606 24,278 56,909 108,010 19,768 21,507 79,693 41,275 150,446 311,291 Items that will not to be reclassified subsequently to profit or loss : ( a ) Re - measurement of defined benefit liability ( b ) Income - tax relating to items that will not be reclassified to profit or loss 8 Total Comprehensive income for the period / year ( 6 + 7 ) 9 Paid - up equity share capital ( face value Re . 1 per share ) 10 Other equity 11 Earnings per equity share ( face value Re . 1 per share ) ( a ) Basic ( in Rs . ) ( b ) Diluted ( in Rs . ) ( 1 ) ( 246 ) ( 6 ) ( 247 ) 86 2 86 ( 488 ) 171 ( 986 ) 344 19,767 5,859 21,347 5,859 79,689 5,859 41,114 5,859 150,129 5,859 310,649 ( not annualised ) ( not annualised ) ( not annualised ) ( not annualised ) ( not annualised ) 5,859 1,586,602 ( Annualised ) 3.37 3.37 3.67 3.67 13.60 13.60 7.04 7.04 25.68 53.13 25.68 53.13 HARMALIO VION OBIND AURO AV HYDERA Page 1 of 4 NS